Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35)
Clinical trial NCT01044459 · COMPLETED
Trial details
- NCT number
- NCT01044459
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2011-04-01
- Enrollment
- 605
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.